Symic Biomedical raised a round of funding on August 05, 2013. Investors include JLabs.
Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The Symic Bio platform of matrix-targeting biotherapeutics builds upon emerging research o…
